SOLICITATION NOTICE
B -- ACTIVX KiNativ Kinase Panel Profiling Services - Presolicitation Notice
- Notice Date
- 9/3/2018
- Notice Type
- Presolicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Station Support/Simplified Acquisitions, 6001 Executive Boulevard, Room 3165, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- 2018-0005355-5015419
- Archive Date
- 12/31/2018
- Point of Contact
- Debra C. Hawkins, Phone: 301-827-7751
- E-Mail Address
-
Debra.Hawkins@nih.gov
(Debra.Hawkins@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Presolicitation Bid Board Notice PRESOLICITATION ‘BID BOARD' NOTICE OF PROPOSED ACQUISITION National Institute on Drug Abuse, Office of Management, Office of Acquisition Neurosciences Consolidated Operation Acquisition Center (COAC) ________________________________________ (FAR Subparts 5.101(a) (2) & 13.105) Announcement Number: 2018-0005355-5015419 Date Posted: September 3, 2018 Date Solicitation Issued: September 3, 2018 Date Responses Due: September 13, 2018 Proposed Award Date: September 15, 2018 Project Title: ACTIVX KiNativ® Kinase Panel Profiling Services Contracting Office: National Institute on Drug Abuse (NIDA), Neurosciences Consolidated Operation Acquisition Center (COAC), Office of Acquisition (OA) Contact Point: Contract Specialist: Debra C. Hawkins; Telephone: 301-827-7751: Email: debra.hawkins@nih.gov Acquisition Authority: This acquisition is being conducted under Federal Acquisition Regulations (FAR) Part 13 - Simplified Acquisition Procedures, and the resultant contract award will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2005-100, August 22, 2018 North American Classification System (NAICS) Code: 541714-Research and Development in Biotechnology (except Nanobiotechnology). Small business size standard: 1,000 Competition Status: This acquisition is being conducted pursuant to FAR Subpart 13.106-1(b)-Soliciting from a single source. (1)(ii) brand name item peculiar to one manufacturer. Description: ACTIVX KiNativ® Kinase Panel Profiling Services (1 Panel Kinase Profiling): Profile eleven (11) compounds at one (1) concentration in a lysate assay. The kinase profiling of the compounds will be performed with the ATP probe and analyzed with the single run-ATP-probe master target list. The total volume of the cell pellet(s) should be 1.5 mL (typically 750-1500 million cells). The 1st dose of compound (n=11). The KiNativ TM platform provides the unprecedented ability to broadly and quantitatively profile protein and lipid kinases in virtually any cell/tissue lysate Closing Statement: Responses to this notice must include sufficient information to establish the interested parties' bona-fide capabilities of providing the product or service. The response shall include: the unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s); product description; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations. In addition, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." All responses must be received by 12:00 noon September 13, 2018 and must reference number: 2018-0005355-5015419. Responses may be submitted electronically to the point cited herein. Fax responses will not be accepted. "All responsible sources may submit response which, if timely received, must be considered by the agency."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-2/2018-0005355-5015419/listing.html)
- Record
- SN05068388-W 20180905/180903230037-facbdb107b4efcf0c38cfc14d7d20f95 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |